An essential role for Ran GTPase in epithelial ovarian cancer cell survival

被引:55
作者
Barres, Veronique [1 ]
Ouellet, Veronique [1 ]
Lafontaine, Julie [1 ]
Tonin, Patricia N. [2 ,3 ,4 ]
Provencher, Diane M. [1 ,5 ,6 ]
Mes-Masson, Anne-Marie [1 ,6 ]
机构
[1] CRCHUM, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada
[2] McGill Univ, Dept Med, Montreal, PQ, Canada
[3] McGill Univ, Dept Human Genet, Montreal, PQ, Canada
[4] RI MUHC, Montreal, PQ H3G 1A4, Canada
[5] Univ Montreal, Dept Obstet Gynecol, Montreal, PQ, Canada
[6] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada
基金
加拿大健康研究院;
关键词
NUCLEAR-PROTEIN; APOPTOSIS; MEMBRANE; EXPRESSION; MIB-1; IDENTIFICATION; MECHANISM; TRANSPORT;
D O I
10.1186/1476-4598-9-272
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: We previously identified that Ran protein, a member of the Ras GTPase family, is highly expressed in high grade and high stage serous epithelial ovarian cancers, and that its overexpression is associated with a poor prognosis. Ran is known to contribute to both nucleocytoplasmic transport and cell cycle progression, but its role in ovarian cancer is not well defined. Results: Using a lentivirus-based tetracycline-inducible shRNA approach, we show that downregulation of Ran expression in aggressive ovarian cancer cell lines affects cellular proliferation by inducing a caspase-3 associated apoptosis. Using a xenograft tumor assay, we demonstrate that depletion of Ran results in decreased tumorigenesis, and eventual tumor formation is associated with tumor cells that express Ran protein. Conclusion: Our results suggest a role for Ran in ovarian cancer cell survival and tumorigenicity and suggest that this critical GTPase may be suitable as a therapeutic target.
引用
收藏
页数:11
相关论文
共 37 条
[1]   High expression of Ran GTPase is associated with local invasion and metastasis of human clear cell renal cell carcinoma [J].
Abe, Hideyuki ;
Kamai, Takao ;
Shirataki, Hiromichi ;
Oyama, Tetsunari ;
Arai, Kyoko ;
Yoshida, Ken-ichiro .
INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (10) :2391-2397
[2]  
Auersperg N, 1997, J CELL PHYSIOL, V173, P261, DOI 10.1002/(SICI)1097-4652(199711)173:2<261::AID-JCP32>3.0.CO
[3]  
2-G
[4]   Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients [J].
Azuma, K ;
Sasada, T ;
Takedatsu, H ;
Shomura, H ;
Koga, M ;
Maeda, Y ;
Yao, A ;
Hirai, T ;
Takabayashi, A ;
Shichijo, S ;
Itoh, K .
CLINICAL CANCER RESEARCH, 2004, 10 (19) :6695-6702
[5]   A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells [J].
Campeau, Eric ;
Ruhl, Victoria E. ;
Rodier, Francis ;
Smith, Corey L. ;
Rahmberg, Brittany L. ;
Fuss, Jill O. ;
Campisi, Judith ;
Yaswen, Paul ;
Cooper, Priscilla K. ;
Kaufmann, Paul D. .
PLOS ONE, 2009, 4 (08)
[6]   Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario [J].
Chipuk, J. E. ;
Bouchier-Hayes, L. ;
Green, D. R. .
CELL DEATH AND DIFFERENTIATION, 2006, 13 (08) :1396-1402
[7]   Genetic immune modulation of Ran GTPase against different microbial pathogens [J].
Chung, SW ;
Huang, XY ;
Song, JL ;
Thomas, R ;
Wong, PMC .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 :3374-3383
[8]   Spatial and temporal coordination of mitosis by Ran GTPase [J].
Clarke, Paul R. ;
Zhang, Chuanmao .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2008, 9 (06) :464-477
[9]   Caspases: the executioners of apoptosis [J].
Cohen, GM .
BIOCHEMICAL JOURNAL, 1997, 326 :1-16
[10]   Now therapeutic agents in ovarian cancer [J].
Collinson, Fiona ;
Jayson, Gordon .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2009, 21 (01) :44-53